KCG
ALT icon

Knight Capital Group’s Altimmune ALT Stock Holding History

Knight Capital Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$110K Buy
+230
New +$114K ﹤0.01% 2919

Other funds holding ALT

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Knight Capital Group's ALT Position: Q2 2013 in Review

Knight Capital Group opened a new position in Altimmune (ALT) in Q2 2013: 230 shares worth $110K. The stake represents ﹤0.01% of the portfolio and ranks #2919 among its holdings.

34 funds tracked by Wall St. Rank hold ALT as of Q2 2013.

  • Knight Capital Group held 230 shares of Altimmune worth $110K as of Q2 2013.
  • Altimmune was a new Knight Capital Group position in Q2 2013.
  • Altimmune made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2919 holding.
  • 34 funds tracked by Wall St. Rank held Altimmune as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.